Navigation Links
New Skin Rejuvenation Discovery Receives Commercial Backing
Date:11/4/2008

BOSTON, Nov. 4 /PRNewswire/ -- Allied Minds funds research to reduce wrinkles by developing a natural replacement for artificial dermal fillers. Allied Minds, a seed investment firm specializing in early stage university business ventures, to fund new research with Lawrence Berkeley National Laboratory through creation of start-up company, ProGDerm, Inc. The research led by Doctors Eva Turley and Mina Bissell will develop a technology based on modulation of the RHAMM protein to induce the controlled generation of fat cells to replace those lost in the aging process. While researching the regulation of cell motility as it relates to the spread of cancer, it was discovered that modulating the RHAMM protein increases the deposition of subcutaneous fat while decreasing unhealthy visceral fat. This technique could provide a non-surgical approach to normalizing skin appearance after the aging process has caused wrinkles and folds and after reconstructive surgery.

This technology would replace the now commonly used artificial dermal fillers prescribed to alleviate the appearance of age related wrinkles. Current filler products are injected under the skin to replace volume lost with the decrease of subcutaneous fat that accompanies the aging process. These filler products however, are of short duration, can cause pain and bruising, require multiple treatments, and often result in an unnatural appearance. Modulating RHAMM proteins represents a natural process that has the potential to actually induce controllable re-growth of the patient's own subcutaneous fat in targeted areas to help restore a youthful appearance without artificial dermal fillers.

The ProGDerm product will initially be administered via injection by trained professionals but has the potential to be delivered as a topical cream. The demand for cosmeceuticals - loosely defined as cosmetic products that have medicinal or drug-like benefits - is rapidly increasing particularly within the skin care segment. "There is a vibrant marketplace for the next generation of dermal products. We look forward to entering this exciting new phase with Dr. Turley and Dr. Bissell," says Allied Minds CEO, Chris Silva.

About Allied Minds, Inc.

Allied Minds, Inc. is the premiere seed organization for early-stage technology. We focus on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, we foster early-stage companies through to success, generating value for all stakeholders. We have a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom. For more information, logon to http://www.alliedminds.com.

About Lawrence Berkeley National Lab

Berkeley Lab is a U.S. Department of Energy national laboratory located in Berkeley, California. It conducts unclassified scientific research and is managed by the University of California. Visit the Lab website at http://www.lbl.gov.


'/>"/>
SOURCE Allied Minds, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nutrition 21 Introduces New Product: Iceland Health Skin Rejuvenation(TM)
2. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
3. New Stretch Mark and Skin Rejuvenation Treatment Introduced to Houston by Dr. Zaniewski-Singh
4. Discovery of sugar sensor in intestine could benefit diabetes
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Stem cell research produces a key discovery for Fragile X Syndrome
7. Welch Foundation gives $1.6 million for drug discovery research
8. New discovery leaves blood-doping athletes scratching their heads
9. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
10. New discovery leaves blood-doping athletes scratching their heads
11. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: